Frontage’s experienced staff and state-of-the-art instrumentation deliver data you can trust. Count on Frontage Laboratories for reliability. From method development or transfer and validation to sample analysis and reporting, Frontage’s bioanalytical team has earned a reputation for consistent and high-quality delivery, project after project. Our bioanalytical expertise extends to combined small and large molecules such as protein, antibody, antibody-drug conjugates as well as biomarker analysis for small molecule drug candidates.

In this eBook, we navigate the landscape of biomarker discovery through genomic profiling, exploring technologies, methods, and applications. We hope this collection of articles creates an appreciation for the wide scope of using sequencing assays for biomarker discovery, drug development, and beyond.

Sequencing the bacterial 16S rRNA gene is an established technique for assessing the phylogenetic diversity of microbial communities. This white paper discusses the methods and process to elucidate that Frontage’s QIIME2 analysis pipeline accurately estimates the composition of microbiome samples, as shown by the similarity to the theoretical abundance.